病毒载体和质粒 DNA 制造市场增长、规模、份额、趋势、关键参与者分析及预测至 2027 年

  • Report Code : TIPRE00003074
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 140
Buy Now

Viral Vector and Plasmid DNA Manufacturing Market Report & Growth Analysis 2027

Buy Now

 

[研究报告] 病毒载体和质粒DNA制造市场规模预计将从2019年的4.594亿美元增长到2027年的22.477亿美元;预计2020-2027年的复合年增长率将达到22.1%。

 

分析师观点:

基因治疗需求的不断增长以及基因编辑技术的进步推动了各种慢性疾病、病毒感染等的治疗方案的发展,这些因素推动了病毒载体和质粒 DNA 制造市场的增长。此外,研究活动的增加和制药和生物技术行业投资的增加以及有利的监管环境预计将推动市场增长。此外,先进计算技术的集成有望在不久的将来进一步扩大病毒载体和质粒 DNA 制造的应用领域,从而推动市场增长。

 

市场概况:

病毒载体是一种用于基因传递和操控的工具。它是经过改造的病毒,经过改造后可携带特定基因并将其传递到细胞中。病毒载体通常用于基因治疗的基因编辑应用,因为它们可以有效地将遗传物质传递到靶细胞中。质粒载体是一小段环状 DNA,与细胞中的染色体 DNA 分离。质粒可以独立复制,常见于细菌中。在研究中,质粒通常用作载体,将基因引入细胞,用于各种目的,例如蛋白质生产或基因工程。病毒载体和质粒 DNA 都是研究中基因传递和操控的重要工具,可让研究人员了解潜在的应用。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

病毒载体和质粒 DNA 制造市场:

病毒载体和质粒 DNA 制造市场
  • Viral Vector and Plasmid DNA Manufacturing Market
    复合年增长率(2019 - 2027 年)
    22.1%
  • 2019 年市场规模
    4.594 亿美元
  • 2027 年市场规模
    22.477 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • Brammer 简介
  • 赛诺菲
  • 富士胶片 Diosynth 生物技术公司
  • 细胞和基因治疗弹射器
  • 眼镜蛇生物制剂
  • 金融向量
  • 钟渊欧洲技术公司
  • 马萨诸塞生物制品公司
  • Spark Therapies公司

区域概况

Viral Vector and Plasmid DNA Manufacturing Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Viral Vector and Plasmid DNA Manufacturing Market产品
  • 病毒载体和非病毒载体
Viral Vector and Plasmid DNA Manufacturing Market应用
  • 癌症
  • 遗传性疾病
  • 病毒感染
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场走向:

 

先进计算技术的集成

人工智能、数据科学、自然语言处理等革命性技术的出现预计将在预测期内重塑医疗技术的未来。然而,基因疗法为疾病治疗提供了创新的解决方案,但其实施面临一些技术挑战。例如,基因替换中的错误可能导致 DNA 发生有害突变,从而导致严重的健康问题。为了在程序中实现高精度,智能算法可以提供重要的方法。此外,大多数参与者都从事新技术的研发,这将满足对现代技术日益增长的需求。例如,2019 年 3 月,Oxford Biomedica 与微软达成战略合作,以改进基因疗法。此外,2020 年 5 月,Dyno Therapeutics 宣布拟投资约 20 亿美元用于设计基于人工智能的基因疗法。这些事件为先进计算技术的整合提供了巨大的机会,最终将在未来几年重新定义基因疗法的概念。

 

节段分析:

根据应用,病毒载体和质粒 DNA 制造市场细分为癌症、遗传性疾病、病毒感染等。癌症领域在 2019 年占据了最大的市场份额,预计同一领域在预测期内的复合年增长率最高,为 22.6%。病毒载体和非病毒载体都有其应用,并且正在研究其在癌症或肿瘤学中的预防和治疗应用。基于病毒载体的抗癌剂免疫或抗癌基因的传递是一些关键的研究领域,这些领域已取得稳步进展。此外,政府批准了用于治疗急性淋巴细胞白血病 (ALL) 和大 B 细胞淋巴瘤的慢病毒载体 CAR-T 细胞疗法,引起了用户的极大关注。病毒载体和非病毒载体已导致基于癌症的先进疗法管线项目大量涌现。例如,大约三分之二的基因治疗研究集中在肿瘤学上。上述因素导致癌症比其他疾病领域占据主导地位。根据产品,全球病毒载体和质粒 DNA 制造市场分为病毒载体和非病毒载体。2019 年,病毒载体细分市场占有最大的市场份额,预计未来几年该细分市场的复合年增长率将最快。

 

区域分析:

根据地域划分,全球病毒载体和质粒 DNA 制造市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。北美占据最大的病毒载体和质粒 DNA 制造市场份额,紧随其后的是欧洲。2019 年,美国占据北美病毒载体和质粒 DNA 制造市场的最大份额。美国市场的增长主要得益于人们对基因治疗益处的认识不断提高、研发活动不断增加以及对治疗慢性病和病毒感染的先进治疗方案的需求不断增长。

此外,由于基因疗法的广泛应用,对病毒载体的需求不断增加,预计也将在预测期内推动美国病毒载体和质粒 DNA 制造市场的增长。此外,由于这种不断增长的需求,市场的主要参与者正致力于扩大其病毒载体制造能力。例如,2020 年 5 月,赛默飞世尔科技公司宣布了扩大病毒载体制造能力的计划。据公司估计,新工厂将于 2022 年投入运营。此外,2020 年 4 月,默克公司宣布了其在美国开设新病毒载体制造工厂的计划。该公司已为此次拟议的扩张投资了约 1.126 亿美元。

在加拿大,由于医疗保健系统的发展和现代细胞相关技术的迅速普及,预计病毒载体和质粒 DNA 制造市场将出现增长。另一方面,在墨西哥,由于人们越来越意识到病毒载体和质粒 DNA 带来的好处,预计病毒载体和质粒 DNA 制造市场可能会迎来增长机会。

 

关键球员分析:

病毒载体和质粒 DNA 制造市场主要由 Brammer Bio、Sanofi、Cardinal Health Inc、FUJIFILM Diosynth Biotechnologies、Cell and Gene Therapy Catapult、Cobra Biologics、FinVector、Kaneka Eurogentec SA、MassBiologics、Spark Therapeutics 和 Uniqure 等公司组成。在病毒载体和质粒 DNA 制造市场的参与者中,Sanofi 和 FUJIFILM Diosynth Biotechnologies 凭借其有机和无机活动成为前两名参与者。

 

病毒载体和质粒 DNA 制造市场报告范围

报告属性细节
2019 年市场规模4.594 亿美元
2027 年市场规模22.477 亿美元
全球复合年增长率(2019 - 2027)22.1%
历史数据2017-2018
预测期2020-2027
涵盖的领域按产品
  • 病毒载体和非病毒载体
按应用
  • 癌症
  • 遗传性疾病
  • 病毒感染
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Brammer 简介
  • 赛诺菲
  • 富士胶片 Diosynth 生物技术公司
  • 细胞和基因治疗弹射器
  • 眼镜蛇生物制剂
  • 金融向量
  • 钟渊欧洲技术公司
  • 马萨诸塞生物制品公司
  • Spark Therapies公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

最近的发展: 

病毒载体和质粒 DNA 制造市场中的公司大量采用并购等无机和有机策略。以下列出了一些近期的关键市场发展: 

  • 2023 年 3 月,Sartorius 以 24 亿欧元(26 亿美元)收购了法国公司 Polyplus。这笔交易让 Sartorius 获得了核酸输送方面的更多专业知识,包括转染试剂和质粒 DNA 设计,所有这些都是生产用于构建细胞和基因疗法的病毒载体的关键要素。
  • 2021 年 7 月,赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.) 在加利福尼亚州卡尔斯巴德开设了一个新的 cGMP 质粒 DNA 制造工厂,使其能够满足对基于质粒 DNA 的疗法和重要基于 mRNA 的疫苗快速增长的需求。
  • 2021 年 3 月,瓦克从韩国首尔的 Helixmith Co Ltd 和韩国首尔的 Medivate Partners LLC 手中收购了药品合同制造商 Genopis Inc. 100% 的股份。相关协议签署后,交易于 2 月底顺利完成,现在收购公司的名称为:Wacker Biotech US Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is viral vector & plasmid DNA manufacturing?

Gene delivery into target cells can be performed using several different vectors. These are broadly classified into viral and non-viral vectors, both of which present benefits and risks. Viral vectors are tools that are commonly used by molecular biologists to deliver genetic material into cells. The non-viral vectors are Naked DNA, particle-based, and chemical-based.

Who are the major players in the viral vector & plasmid DNA manufacturing market?

The viral vector & plasmid DNA manufacturing market majorly consists of the players such as Brammer Bio, Sanofi, Cardinal Health Inc., FUJIFILM Diosynth Biotechnologies. Cell and Gene Therapy Catapult, Cobra Biologics, FinVector, Kaneka Eurogentec S.A., MassBiologics, Spark Therapeutics, and Uniqure among others.

What are the driving factors for the viral vector & plasmid DNA manufacturing market across the globe?

Driving factor such as growing awareness of gene therapy and increasing prevalence of genetic disorders and infectious diseases across the world are expected to upsurge the market growth. In addition, growth in the global healthcare market is likely to have a positive impact on the market in the coming years.

The List of Companies - Portable and Wearable Dialysis Devices Market

  1. Brammer Bio
  2. Sanofi
  3. FUJIFILM Diosynth Biotechnologies
  4. Cell and Gene Therapy Catapult
  5. Cobra Biologics
  6. FinVector
  7. Kaneka Eurogentec S.A.
  8. MassBiologics
  9. Spark Therapeutics
  10. Uniqure

 

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..